Skip to main content

The Choice of Proton Pump Inhibitor: Does it matter?

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract:

Abstract:

Proton pump inhibitors are used at different dosages for the treatment of acid-related gastrointestinal disorders, such as gastro-oesophageal reflux and peptic ulcer disease. Comparisons of four different proton pump inhibitors: lansoprazole, omeprazole, pantoprazole, and rabeprazole show that they all have similar potency and efficacy. Rabeprazole, however, displays a slightly more rapid onset of acid inhibition than the others; the clinical advantage of this seems limited. The S-isomer of omeprazole, esomeprazole, exhibits a somewhat higher potency than the other proton pump inhibitors. Reports supporting a clinical advantage of this property are not convincing. To conclude, all inhibitors seem comparable as regards inhibition of gastric acid secretion.

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1742-7843.2004.pto940302.x

Affiliations: Clinical Pharmacology, Department of Medicine, Karolinska Hospital, Stockholm, Sweden

Publication date: March 1, 2004

More about this publication?
  • Formerly Pharmacology & Toxicology
mksg/pto/2004/00000094/00000003/art00002
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more